Evidence map›Paper›PMID 31293115›Full record

ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2019

[Evaluation of a rapid assay for detection of PBP2a Staphylococcus aureus].

R Sáinz-Rodríguez, I de Toro-Peinado, M Valverde-Troya, M P Bermúdez Ruíz, B Palop-Borrás

Abstract readEvaluation Study
In one paragraph

Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Detection ofPathogens (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R Sáinz-Rodríguez
I de Toro-Peinado
M Valverde-Troya
M P Bermúdez Ruíz
B Palop-BorrásBegoña Palop-Borrás, Servicio de Microbiología, Hospital Regional Universitario de Málaga, Avda. Carlos Haya, s/n 29010 Málaga, Spain. bpalop@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMethicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing both healthcare-associated and community-acquired infection. Rapid and accurate detection of this pathogen is crucial for the use of appropriate antimicrobial therapy and the control of nosocomial spread.

methodsA total of 107 S. aureus strains were assayed for methicillin resistance: Vitek2® (bioMérieux), CHROMagarTM MRSA II (BD Becton Dickinson), disk diffusion in agar for cefoxitin 30 μg and immunochromatography PBP2a SA Culture Colony Test (AlereTM). The results of conventional tests were compared with the "gold standard" PCR test for mecA gene.

resultsSensitivity and specificity were: disk diffusion for cefoxitin 100% and 100% respectively, Vitek2® 100 and 100%, CHROMagarTM MRSA II 100 and 96%, and ICPBP2a detection 98,25% and 100%.

conclusionsICPBP2a Culture Colony Test (AlereTM) is fast, efficient and economical technique for detection of penicillin binding protein 2a (PBP2a) from isolates. This assay is a useful tool for the management of hospital outbreaks.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBacteriological TechniquesCefoxitinCommunity-Acquired InfectionsCross InfectionCulture MediaDisk Diffusion Antimicrobial TestsHumansImmunoassayMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPenicillin-Binding ProteinsPolymerase Chain ReactionSensitivity and SpecificityAnti-Bacterial AgentsBacterial ProteinsCefoxitinCulture MediamecA protein, Staphylococcus aureusPenicillin-Binding Proteins

Identifiers

PMID31293115
PMCPMC6719650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.